4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001185945-26-000002
Director sold 8,346 shares at $7.04 ($58,756)
- Director acquired 14,344 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A Director | 2026-05-11 | Option exercise 10b5-1 | +14,344 | $2.44 | $34,999 | 71,423 | D |
| RALLIS CHRIS A Director | 2026-05-11 | Sale 10b5-1 | −8,346 | $7.04 | $58,756 | 63,077 | D |
| Derivatives | |||||||
| RALLIS CHRIS A Director | 2026-05-11 | Option exercise · Stock Option 10b5-1 | −14,344 | $2.44 | $34,999 | 186,189 | D |
| Open-market sales · 8,346 sh · avg $7.04 · $58,756 | |||||||
Loading xslF345X06/form4-05122026_040501.xml…